Holly John

Agios Pharmaceuticals

BIOGRAPHY

Holly John is the Senior Director of Global Patient Advocacy at Agios Pharmaceuticals. Her work focuses on rare blood disorders, including sickle cell disease, thalassemia, and pyruvate kinase (PK) deficiency. She ensures community voices inform clinical development and commercialization.

Holly builds genuine, long-term relationships with patients, caregivers, advocates, and physicians, engaging communities as true partners early in development. Her focus is on translating these insights into practical actions that improve care, expand access, and address unmet needs in rare blood disorders.